Multidisciplinary treatment model, including surgery, chemotherapy, radiotherapy, endocrine therapy and anti-human epidermal growth factor receptor 2 (HER-2) based targeted therapy, is the standard of care for breast cancer (3). The gene discussed is ERBB2; the disease is breast cancer.